Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RVNC - Revance Therapeutics GAAP EPS of -$0.74 revenue of $49.3M

RVNC - Revance Therapeutics GAAP EPS of -$0.74 revenue of $49.3M

Revance Therapeutics Inc.

2023-05-09 16:48:12 ET

  • Revance Therapeutics press release ( NASDAQ: RVNC ): Q1 GAAP EPS of -$0.74.
  • Revenue of $49.3M (+95.2% Y/Y).
  • Q1 RHA® Collection revenue of $30.3 million, a YOY increase of 45.3%.- Q1 DAXXIFY® revenue of $15.4 million, driven by PrevU and March launch.
  • Cash, cash equivalents and short-term investments as of March 31, 2023 were $273.9 million.

For further details see:

Revance Therapeutics GAAP EPS of -$0.74, revenue of $49.3M
Stock Information
Company Name: Revance Therapeutics Inc.
Stock Symbol: RVNC
Market: NASDAQ
Website: revance.com
Menu
RVNC RVNC Quote RVNC Short RVNC News RVNC Articles RVNC Message Board
Get RVNC Alerts

News, Short Squeeze, Breakout and More Instantly...